91 related articles for article (PubMed ID: 20808065)
1. [Septic shock due to fluoroquinolone-resistant Escherichia coli after trans-rectal prostate needle biopsy].
Kato R; Suzuki Y; Matsuura T; Sato K; Shimaya R; Fujishima Y; Tokiwa S; Obara W
Hinyokika Kiyo; 2010 Aug; 56(8):453-6. PubMed ID: 20808065
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
[TBL] [Abstract][Full Text] [Related]
3. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
Young JL; Liss MA; Szabo RJ
Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041
[TBL] [Abstract][Full Text] [Related]
4. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
[TBL] [Abstract][Full Text] [Related]
5. Editorial comment. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
Hernandez-Graulau JM
Urology; 2009 Aug; 74(2):338-9; author reply 339. PubMed ID: 19646618
[No Abstract] [Full Text] [Related]
6. [Case of septic shock caused by extended spectrum β-lactamase producing Escherichia coli after transrectal prostate biopsy, successfully treated by endotoxin adsorption therapy].
Kohno Y; Fukui N; Kageyama Y; Higashi Y
Hinyokika Kiyo; 2013 Sep; 59(9):593-6. PubMed ID: 24113759
[TBL] [Abstract][Full Text] [Related]
7. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature.
Miura T; Tanaka K; Shigemura K; Nakano Y; Takenaka A; Fujisawa M
Int J Urol; 2008 May; 15(5):457-9. PubMed ID: 18452466
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of catheter-associated urinary tract infections and multi-drug-resistant Escherichia coli isolates from the urine of dogs with indwelling urinary catheters.
Ogeer-Gyles J; Mathews K; Weese JS; Prescott JF; Boerlin P
J Am Vet Med Assoc; 2006 Nov; 229(10):1584-90. PubMed ID: 17107313
[TBL] [Abstract][Full Text] [Related]
9. [Spondylodiscitis as a complication to ultrasound-guided transrectal prostatic biopsy].
Koefoed-Nielsen J; Mommsen S
Ugeskr Laeger; 2002 Dec; 165(1):51-2. PubMed ID: 12529951
[TBL] [Abstract][Full Text] [Related]
10. [A serious and unexpected infectious complication after transrectal prostate biopsy].
Nguyen BV; Cottrel M; Ralec B; Eyrieux S; Giacardi C; Commandeur D; Ahmed MO
Med Mal Infect; 2009 Sep; 39(9):735-8. PubMed ID: 19269759
[TBL] [Abstract][Full Text] [Related]
11. Septicemia as a complication of percutaneous liver biopsy.
LoIudice T; Buhac I; Balint J
Gastroenterology; 1977 May; 72(5 Pt 1):949-51. PubMed ID: 321291
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy.
Lee C; You D; Jeong IG; Hong JH; Choo MS; Ahn H; Ahn TY; Kim CS
Korean J Urol; 2015 Jun; 56(6):466-72. PubMed ID: 26078845
[TBL] [Abstract][Full Text] [Related]
13. [Sepsis following transrectal prostate biopsy: a report of 2 cases and reviewed similar cases in Japan].
Hoshi A; Nitta M; Hongoh S; Hanai K; Nishikawa Z; Kobayashi Y; Shima M; Hanai T; Hyochi N; Usui Y; Miyakita H; Terachi T
Hinyokika Kiyo; 2006 Aug; 52(8):645-9. PubMed ID: 16972630
[TBL] [Abstract][Full Text] [Related]
14. Development of antimicrobial drug resistance in rectal Escherichia coli isolates from dogs hospitalized in an intensive care unit.
Ogeer-Gyles J; Mathews KA; Sears W; Prescott JF; Weese JS; Boerlin P
J Am Vet Med Assoc; 2006 Sep; 229(5):694-9. PubMed ID: 16948576
[TBL] [Abstract][Full Text] [Related]
15. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
Johnson L; Sabel A; Burman WJ; Everhart RM; Rome M; MacKenzie TD; Rozwadowski J; Mehler PS; Price CS
Am J Med; 2008 Oct; 121(10):876-84. PubMed ID: 18823859
[TBL] [Abstract][Full Text] [Related]
16. Urinary bactericidal activity of single doses (250, 500, 750 and 1000 mg) of levofloxacin against fluoroquinolone-resistant strains of Escherichia coli.
Stein GE; Schooley SL; Nicolau DP
Int J Antimicrob Agents; 2008 Oct; 32(4):320-5. PubMed ID: 18715762
[TBL] [Abstract][Full Text] [Related]
17. In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
Cattoir V; Lesprit P; Lascols C; Denamur E; Legrand P; Soussy CJ; Cambau E
J Antimicrob Chemother; 2006 Nov; 58(5):1054-7. PubMed ID: 16984897
[TBL] [Abstract][Full Text] [Related]
18. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
[TBL] [Abstract][Full Text] [Related]
19. Extended-spectrum beta-lactamase gram-negative sepsis following prostate biopsy: implications for use of fluoroquinolone prophylaxis.
Cannon GM; Smaldone MC; Paterson DL
Can J Urol; 2007 Aug; 14(4):3653-5. PubMed ID: 17784990
[TBL] [Abstract][Full Text] [Related]
20. Gram-negative bacteremia after transrectal needle biopsy of the prostate.
Edson RS; Van Scoy RE; Leary FJ
Mayo Clin Proc; 1980 Aug; 55(8):489-91. PubMed ID: 6995720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
